(lp0
S'MiMedx Group Inc  Moves Higher on Volume Spike for March 17 Equities.com - 18 hours ago MiMedx Group Inc  traded on unusually high volume on Mar. 17, as the stock gained 2.19% to close at $8.85. On the day, MiMedx Group Inc saw 1.62 million shares trade hands on 5,067 trades. Considering that the stock averages only a daily volume&nbsp;...Should You Buy, Sell, Or Hold?  Gartner, Inc. , MiMedx Group, Inc.  - USA Commerce Daily'
p1
aS'MiMedx to Host Shareholder call on March 9, 2017 to present various strategic ... PR Newswire  - Mar 2, 2017 MARIETTA, Ga., March 2, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and&nbsp;...'
p2
aS'MiMedx Group, Inc.: A Fundamentally Solid Biomaterials Company Poised For Growth Seeking Alpha - Dec 9, 2016 I recommend buying a long position in MiMedx Group, Inc., trading at $8.29 per share at the time this analysis was conducted, as I believe the market is undervaluing this security by 30-40%.'
p3
aS'MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo PR Newswire  - Jul 25, 2016 MARIETTA, Ga., July 25, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p4
aS'MiMedx Files Lawsuits Against Two Additional Former Sales Employees For Breach ... PR Newswire  - Dec 30, 2016 MARIETTA, Ga., Dec. 30, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p5
aS'Scientific Study Confirms MiMedx dHACM Allograft Promotes Cardiac Repair ... PR Newswire  - Jan 24, 2017 MARIETTA, Ga., Jan. 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...MiMedx touts data from study of AmnioFix, EpiFix allograft - Mass Device'
p6
aS"MiMedx To Present At Canaccord's 12th Annual Musculoskeletal Conference PR Newswire  - Mar 8, 2017 MARIETTA, Ga., March 8, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and other birth tissues, human skin and bone, and patent-protected processes and&nbsp;...MiMedx Group Inc  Earns Overweight Rating from Analysts at Piper Jaffray ... - The Cerbat GemPiperJaffray Initiates Coverage On MiMedx Group Inc to Overweight with Price ... - Energy Index"
p7
aS"MiMedx Board of Directors Authorizes $10 Million Increase to the Company's ... PR Newswire  - Feb 6, 2017 MARIETTA, Ga., Feb. 6, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;..."
p8
aS'MiMedx Comments On FDA Decision Not To Finalize HCT/P Guidance Documents This Year PR Newswire  - Feb 3, 2017 MARIETTA, Ga., Feb. 3, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p9
aS'MiMedx Announces 2016 Record Results PR Newswire  - Feb 23, 2017 23, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care,&nbsp;...How Analysts See MiMedx Group Inc  Perform Over The Next Year? - Simply Wall StMIMEDX GROUP, INC.  Files An 8-K Results of Operations and ... - Market Exclusive'
p10
a.